淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4827人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997975, encodeId=0e8b199e9750f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：一种新的儿童急性淋巴细胞白血病风险分层方法, objectType=article, longId=188246, objectId=11c418824652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11c418824652, replyNumber=0, likeNumber=139, createdTime=2020-10-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11c418824652, moduleTitle=Blood：一种新的儿童急性淋巴细胞白血病风险分层方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11c418824652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997977, encodeId=982b199e977d7, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Cancer Discorvery：科学家揭秘诱发急性淋巴细胞白血病复发的细胞特性, objectType=article, longId=190897, objectId=7b2119089e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b2119089e77, replyNumber=0, likeNumber=56, createdTime=2020-11-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b2119089e77, moduleTitle=Cancer Discorvery：科学家揭秘诱发急性淋巴细胞白血病复发的细胞特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b2119089e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997969, encodeId=b94d199e9691a, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=李建勇教授：经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗, objectType=article, longId=186262, objectId=bdf5186262fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdf5186262fb, replyNumber=0, likeNumber=89, createdTime=2020-08-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdf5186262fb, moduleTitle=李建勇教授：经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf5186262fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997963, encodeId=61f7199e9633c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=FDA批准阿斯利康的BTK抑制剂Calquence，用于治疗慢性淋巴细胞白血病和小淋巴细胞淋巴瘤, objectType=article, longId=183460, objectId=fde3183460df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde3183460df, replyNumber=0, likeNumber=71, createdTime=2020-02-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde3183460df, moduleTitle=FDA批准阿斯利康的BTK抑制剂Calquence，用于治疗慢性淋巴细胞白血病和小淋巴细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fde3183460df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997980, encodeId=a567199e98013, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, objectType=article, longId=191730, objectId=1f9c191e301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9c191e301a, replyNumber=0, likeNumber=114, createdTime=2021-03-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9c191e301a, moduleTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f9c191e301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997967, encodeId=43cf199e96712, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2019 ASH：阿斯利康的BTK抑制剂Calquence提高了慢性淋巴细胞白血病患者的无进展生存期, objectType=article, longId=184850, objectId=079b184850dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=079b184850dc, replyNumber=0, likeNumber=132, createdTime=2020-03-08, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=079b184850dc, moduleTitle=2019 ASH：阿斯利康的BTK抑制剂Calquence提高了慢性淋巴细胞白血病患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=079b184850dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997954, encodeId=a03e199e95407, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=强生BTK抑制剂Imbruvica获欧盟批准扩大两个适应症：慢性淋巴细胞白血病和瓦尔德斯特罗姆巨球蛋白血症, objectType=article, longId=177713, objectId=d3701e7713cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3701e7713cf, replyNumber=0, likeNumber=64, createdTime=2020-02-14, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3701e7713cf, moduleTitle=强生BTK抑制剂Imbruvica获欧盟批准扩大两个适应症：慢性淋巴细胞白血病和瓦尔德斯特罗姆巨球蛋白血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3701e7713cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997953, encodeId=92a9199e95344, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：Cirmtuzumab的抗慢性淋巴细胞白血病机制！, objectType=article, longId=177656, objectId=a2e81e76561a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2e81e76561a, replyNumber=0, likeNumber=70, createdTime=2020-07-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2e81e76561a, moduleTitle=Blood：Cirmtuzumab的抗慢性淋巴细胞白血病机制！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2e81e76561a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997971, encodeId=16f0199e971fd, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：急性淋巴细胞白血病（2020.V1）, objectType=article, longId=186751, objectId=9796186e51b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9796186e51b4, replyNumber=0, likeNumber=27, createdTime=2020-06-14, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9796186e51b4, moduleTitle=NCCN临床实践指南：急性淋巴细胞白血病（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9796186e51b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997979, encodeId=3f9d199e979d0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND, objectType=article, longId=191470, objectId=27641914e046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27641914e046, replyNumber=0, likeNumber=101, createdTime=2020-08-08, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27641914e046, moduleTitle=中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27641914e046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997961, encodeId=e6fa199e9616b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Neurology：急性淋巴细胞白血病初次复发表现为视神经和动眼神经浸润, objectType=article, longId=182160, objectId=f07a182160b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f07a182160b6, replyNumber=0, likeNumber=71, createdTime=2020-09-16, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f07a182160b6, moduleTitle=Neurology：急性淋巴细胞白血病初次复发表现为视神经和动眼神经浸润, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f07a182160b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997978, encodeId=4eca199e97890, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：整合素α6介导急性B淋巴细胞白血病耐药性的产生, objectType=article, longId=191221, objectId=a8c7191221b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8c7191221b6, replyNumber=0, likeNumber=85, createdTime=2021-01-31, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8c7191221b6, moduleTitle=Blood：整合素α6介导急性B淋巴细胞白血病耐药性的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8c7191221b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997960, encodeId=1771199e96061, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V2）, objectType=article, longId=181796, objectId=a46a181e96e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a46a181e96e1, replyNumber=0, likeNumber=27, createdTime=2019-11-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a46a181e96e1, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a46a181e96e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997974, encodeId=57fe199e9746f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：CD49d促进慢性淋巴细胞白血病进展, objectType=article, longId=187614, objectId=364e18e61427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364e18e61427, replyNumber=0, likeNumber=123, createdTime=2020-09-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364e18e61427, moduleTitle=Blood：CD49d促进慢性淋巴细胞白血病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364e18e61427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997959, encodeId=7f81199e959d2, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Infect Dis：人T淋巴细胞白血病1型病毒感染相关疾病研究, objectType=article, longId=181768, objectId=2f24181e681e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f24181e681e, replyNumber=0, likeNumber=84, createdTime=2020-06-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f24181e681e, moduleTitle=Lancet Infect Dis：人T淋巴细胞白血病1型病毒感染相关疾病研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f24181e681e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997964, encodeId=ce7f199e96431, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Clinica Chimica Acta：一种性能优秀的癌症筛查包可用于早期和急性淋巴细胞白血病检测？, objectType=article, longId=183501, objectId=f9701835014d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9701835014d, replyNumber=0, likeNumber=59, createdTime=2020-08-06, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9701835014d, moduleTitle=Clinica Chimica Acta：一种性能优秀的癌症筛查包可用于早期和急性淋巴细胞白血病检测？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9701835014d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997973, encodeId=9064199e9739b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性, objectType=article, longId=187564, objectId=83f918e56435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83f918e56435, replyNumber=0, likeNumber=63, createdTime=2020-09-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83f918e56435, moduleTitle=Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83f918e56435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997962, encodeId=bb6a199e96242, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定, objectType=article, longId=182512, objectId=6d2018251202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d2018251202, replyNumber=0, likeNumber=65, createdTime=2020-04-30, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d2018251202, moduleTitle=Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d2018251202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997965, encodeId=0026199e9654a, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=具备更好的靶选择性，ORR超过88%！复发难治慢性淋巴细胞白血病/小细胞淋巴瘤带来治疗新选择, objectType=article, longId=184372, objectId=a2ac1843e2f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2ac1843e2f7, replyNumber=0, likeNumber=69, createdTime=2020-04-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2ac1843e2f7, moduleTitle=具备更好的靶选择性，ORR超过88%！复发难治慢性淋巴细胞白血病/小细胞淋巴瘤带来治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2ac1843e2f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997958, encodeId=b7a1199e95897, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=J Prev Med Public Health：孕期叶酸补充有益于预防后代急性淋巴细胞白血病的发生, objectType=article, longId=181668, objectId=8af2181668d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8af2181668d9, replyNumber=0, likeNumber=40, createdTime=2020-07-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8af2181668d9, moduleTitle=J Prev Med Public Health：孕期叶酸补充有益于预防后代急性淋巴细胞白血病的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8af2181668d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：一种新的儿童急性淋巴细胞白血病风险分层方法

2020-10-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Cancer Discorvery：科学家揭秘诱发急性淋巴细胞白血病复发的细胞特性

2020-11-21

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

李建勇教授：经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗

2020-08-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

FDA批准阿斯利康的BTK抑制剂Calquence，用于治疗慢性淋巴细胞白血病和小淋巴细胞淋巴瘤

2020-02-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准

2021-03-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2019 ASH：阿斯利康的BTK抑制剂Calquence提高了慢性淋巴细胞白血病患者的无进展生存期

2020-03-08

仁医06 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

强生BTK抑制剂Imbruvica获欧盟批准扩大两个适应症：慢性淋巴细胞白血病和瓦尔德斯特罗姆巨球蛋白血症

2020-02-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：Cirmtuzumab的抗慢性淋巴细胞白血病机制！

2020-07-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：急性淋巴细胞白血病（2020.V1）

2020-06-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND

2020-08-08

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Neurology：急性淋巴细胞白血病初次复发表现为视神经和动眼神经浸润

2020-09-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：整合素α6介导急性B淋巴细胞白血病耐药性的产生

2021-01-31

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V2）

2019-11-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：CD49d促进慢性淋巴细胞白血病进展

2020-09-21

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Infect Dis：人T淋巴细胞白血病1型病毒感染相关疾病研究

2020-06-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Clinica Chimica Acta：一种性能优秀的癌症筛查包可用于早期和急性淋巴细胞白血病检测？

2020-08-06

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性

2020-09-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定

2020-04-30

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

具备更好的靶选择性，ORR超过88%！复发难治慢性淋巴细胞白血病/小细胞淋巴瘤带来治疗新选择

2020-04-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

J Prev Med Public Health：孕期叶酸补充有益于预防后代急性淋巴细胞白血病的发生

2020-07-07

科室
- - 订阅+
  - 更多科室
工具
服务